CN Stock MarketDetailed Quotes

301096 Hangzhou Bio-Sincerity Pharma-Tech

Watchlist
  • 55.13
  • -1.27-2.25%
Market Closed Jul 2 15:00 CST
6.00BMarket Cap20.95P/E (TTM)

Hangzhou Bio-Sincerity Pharma-Tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Bio-Sincerity Pharma-Tech Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

215.70M

+34.04%
EPS(YoY)

0.46

+43.75%
Analyst Rating

Strong Buy

Jul 2, 2024

Hangzhou Bio-Sincerity Pharma-Tech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.798B--
--2024/FY-- / 1.365B--
--2023/FY1.017B / 922.000M--
--2022/FY607.411M / 622.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.798B--
--2024/FY-- / 1.365B--
--2023/FY1.017B / 922.000M--
--2022/FY607.411M / 622.000M--

Hangzhou Bio-Sincerity Pharma-Tech Earnings Reports

  • Baicheng Pharmaceutical: Report for the first quarter of 2024

    Apr 23 00:00

  • Baicheng Pharmaceutical: 2023 Annual Report

    Apr 23 00:00

  • Baicheng Pharmaceutical: 2023 Annual Report Summary

    Apr 23 00:00

  • Baicheng Pharmaceutical: Report for the third quarter of 2023

    Oct 26, 2023 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 2, 2024

    Strong Buy

    • Strong Buy

      87.50%

    • Buy

      12.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg